Channels
Special Offers & Promotions
« Tuesday, 15 October 2013 »
- 3rd Oncology Biomarkers Congress 2013 - (14/10/2013 10:00 - 15/10/2013 18:00)
Oxford Global is proud to present the 3rd Oncology Biomarkers Congress to be held on the 10th -11th October 2013,
Manchester.
It is to be co-located with our Oncology Clinical Development Congress. Over the 2 days, the event provides a first class educational and networking opportunity for over 150 attendees to gain knowledge and insights into the Oncology biomarkers market. The event will bring together key scientists whose expertise is focused on biomarkers, companion diagnostics, personalized medicine, safety studies, translational medicine and decision making in the oncology therapeutic area, from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe. - 2nd Oncology Clinical Development Congress 2013 - (14/10/2013 10:00 - 15/10/2013 18:00)
The global oncology market faces the dual problem of increasing drug development expenses and the high failure rate of oncology drugs. The current ROI in drug development has been estimated to be as low as 0.3%. As experts try to reduce expenses and increase their chances of success, the industry is witnessing an increased emphasis on early decision making, adaptive programme design and strategic clinical alliances. - Orphan Drugs & Rare Diseases - (14/10/2013 10:00 - 15/10/2013 18:00)
Recent years have seen huge growth in orphan drug development, but also a time of increased pressure as many leading blockbuster drugs soon come off patent.
Media Partners